Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of maraviroc on immunologic recovery in HIV-infected patients
2009-012543-42Phase 4Active
- Sponsor
- Fundació Clínic per a la Recerca Biomèdica
- Start
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of maraviroc in human immunodeficiency virus infection (HIV) (2 arms), sponsored by Fundació Clínic per a la Recerca Biomèdica. Primary endpoint: Median change in CD4+ T-cell count at 24 weeks. Started Nov 2009; status: active.
02
Drugs
maraviroc
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2009-012543-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012543-42.